Abstract
Directly modulating the activity of genome-editing proteins has the potential to increase their specificity by reducing activity following target locus modification. We developed Cas9 nucleases that are activated by the presence of a cell-permeable small molecule by inserting an evolved 4-hydroxytamoxifen–responsive intein at specific positions in Cas9. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
Cellular & Molecular Biology Letters Open Access 17 May 2023
-
Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
Nature Communications Open Access 23 June 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Jinek, M. et al. Science 337, 816–821 (2012).
Mali, P. et al. Science 339, 823–826 (2013).
Cong, L. et al. Science 339, 819–823 (2013).
Jinek, M. et al. eLife 2, e00471 (2013).
Pattanayak, V. et al. Nat. Biotechnol. 31, 839–843 (2013).
Fu, Y. et al. Nat. Biotechnol. 31, 822–826 (2013).
Hsu, P.D. et al. Nat. Biotechnol. 31, 827–832 (2013).
Cho, S.W. et al. Genome Res. 24, 132–141 (2014).
Tsai, S.Q. et al. Nat. Biotechnol. 33, 187–197 (2015).
Mali, P. et al. Nat. Biotechnol. 31, 833–838 (2013).
Ran, F.A. et al. Cell 154, 1380–1389 (2013).
Guilinger, J.P., Thompson, D.B. & Liu, D.R. Nat. Biotechnol. 32, 577–582 (2014).
Tsai, S.Q. et al. Nat. Biotechnol. 32, 569–576 (2014).
Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M. & Joung, J.K. Nat. Biotechnol. 32, 279–284 (2014).
Kim, S., Kim, D., Cho, S.W., Kim, J. & Kim, J.S. Genome Res. 24, 1012–1019 (2014).
Ramakrishna, S. et al. Genome Res. 24, 1020–1027 (2014).
Zuris, J.A. et al. Nat. Biotechnol. 33, 73–80 (2015).
Wang, T., Wei, J.J., Sabatini, D.M. & Lander, E.S. Science 343, 80–84 (2014).
González, F. et al. Cell Stem Cell 15, 215–226 (2014).
Pruett-Miller, S.M., Reading, D.W., Porter, S.N. & Porteus, M.H. PLoS Genet. 5, e1000376 (2009).
Buskirk, A.R., Ong, Y.C., Gartner, Z.J. & Liu, D.R. Proc. Natl. Acad. Sci. USA 101, 10505–10510 (2004).
Yuen, C.M., Rodda, S.J., Vokes, S.A., McMahon, A.P. & Liu, D.R. J. Am. Chem. Soc. 128, 8939–8946 (2006).
Peck, S.H., Chen, I. & Liu, D.R. Chem. Biol. 18, 619–630 (2011).
Jinek, M. et al. Science 343, 1247997 (2014).
Danielian, P.S., White, R., Hoare, S.A., Fawell, S.E. & Parker, M.G. Mol. Endocrinol. 7, 232–240 (1993).
Zetsche, B., Volz, S.E. & Zhang, F. Nat. Biotechnol. 33, 139–142 (2015).
Shcherbakova, D.M. & Verkhusha, V.V. Nat. Methods 10, 751–754 (2013).
Acknowledgements
This work was supported by National Institutes of Health R01 GM095501, Defense Advanced Research Projects Agency HR0011-11-2-0003 and N66001-12-C-4207 and the Howard Hughes Medical Institute. K.M.D. acknowledges the Natural Sciences and Engineering Research Council of Canada (NSERC) for a Postgraduate Scholarship–Doctoral (PGS D) award. J.A.Z. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 106601-2). We are grateful to J. Doudna, S. Sternberg, D. Taylor, M. Jinek and F. Jiang for providing the structural coordinates of Cas9 and to J. Guilinger, Y. Kim, M. Li and A. Badran for helpful discussions.
Author information
Authors and Affiliations
Contributions
K.M.D., V.P., D.B.T. and D.R.L. designed the research. K.M.D. performed the experiments, and J.A.Z. assisted with high-throughput sequencing. K.M.D., V.P., D.B.T. and J.A.Z. analyzed the data. D.R.L. supervised the research. All authors wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The co-authors have filed a provisional patent application related to this work. D.R.L is a consultant for Editas Medicine, a company that applies genome-editing technologies.
Supplementary information
Supplementary Text and Figures
Supplementary Results, Supplementary Figures 1–8, Supplementary Tables 1–7 and Supplementary Notes. (PDF 1802 kb)
Supplementary Data Set 2
Indel sequences used to calculate modification frequencies in Fig. 2b–e and Supplementary Figures 5–7 (XLSX 126 kb)
Rights and permissions
About this article
Cite this article
Davis, K., Pattanayak, V., Thompson, D. et al. Small molecule–triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol 11, 316–318 (2015). https://doi.org/10.1038/nchembio.1793
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1793
This article is cited by
-
Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
Cellular & Molecular Biology Letters (2023)
-
Nature-inspired protein ligation and its applications
Nature Reviews Chemistry (2023)
-
A chemically controlled Cas9 switch enables temporal modulation of diverse effectors
Nature Chemical Biology (2023)
-
Genetic advancements in obesity management and CRISPR–Cas9-based gene editing system
Molecular and Cellular Biochemistry (2023)
-
Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing
Cell Biology and Toxicology (2023)